{"transactions":[{"id":2255139,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":126869,"kind":"person","name":"Tran Tram","position":1,"cik":"0001892918","reported_name":"Tran Tram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:13:28.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000034","document":"wf-form4_165359597719078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000034/wf-form4_165359597719078.xml","form_type":"4"}},{"id":2514889,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":126869,"kind":"person","name":"Tran Tram","position":1,"cik":"0001892918","reported_name":"Tran Tram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-12T11:22:08.000Z","date":"2021-11-09","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on November 9, 2021, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in three equal annual installments beginning one year from the grant date."}],"balance_after":44000,"derivative":{"exercise_price":3.5,"expiration_date":"2031-11-09","underlying":"Common Shares","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001447028-21-000064","document":"wf-form4_163671611466902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000064/wf-form4_163671611466902.xml","form_type":"4"}}]}